Pharma-Gewinne infizieren medizinische Studien
E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER
Vienna, Virginia https://www.nvic.org
BL Fisher Note:
Junk science: the best that drug company money can buy. Every
epidemiological study published by researchers funded by drug companies that deny any link between vaccines and autism or other immune and brain dysfunction is suspect and should be investigated. The future of our nation is at stake.
Drug profits infect medical studies
"(...) SEVERAL OF OUR most venerated scientific journals have recently been besmirched by allegations of scientific misconduct. Shocking? We should be just as shocked as Inspector Renault when he discovered gambling at Rick's Cafe in Casablanca.
First, the New England Journal of Medicine made public its concerns about crucial data having been withheld from its 2000 report on a study sponsored by Merck exaggerating the safety of its blockbuster drug Vioxx, now withdrawn. Then the lead author of a seminal article published in the journal Science reporting the creation of viable stem cells from cloned human embryos admitted he falsified results and resigned his academic post in disgrace.
This week brings the news that a Johnson & Johnson subsidiary failed to include the deaths of two patients in a clinical trial of its new drug for heart failure, Natrecor, in an article published in the Journal of Emergency Medicine.
Why shouldn't we be surprised? Because over the last 25 years, clinical research has been largely privatized. Three-quarters of the clinical studies published in the three most respected medical journals (the New England Journal of Medicine, the Journal of the American Medical Assn. and the Lancet) are now commercially funded. As a result, our medical knowledge grows not in the direction that best improves our health but toward corporate profits, the way that plants grow toward sunlight. (...)"
Hier weiterlesen:
https://www.latimes.com/news/opinion/commentary/la-oe-abramson7jan07,0,1957242.story?coll=la-news-comment-opinions
Los Angeles Times, January 7, 2006
Aus: impf-report Newsletter Nr. 02/2006
Vienna, Virginia https://www.nvic.org
BL Fisher Note:
Junk science: the best that drug company money can buy. Every
epidemiological study published by researchers funded by drug companies that deny any link between vaccines and autism or other immune and brain dysfunction is suspect and should be investigated. The future of our nation is at stake.
Drug profits infect medical studies
"(...) SEVERAL OF OUR most venerated scientific journals have recently been besmirched by allegations of scientific misconduct. Shocking? We should be just as shocked as Inspector Renault when he discovered gambling at Rick's Cafe in Casablanca.
First, the New England Journal of Medicine made public its concerns about crucial data having been withheld from its 2000 report on a study sponsored by Merck exaggerating the safety of its blockbuster drug Vioxx, now withdrawn. Then the lead author of a seminal article published in the journal Science reporting the creation of viable stem cells from cloned human embryos admitted he falsified results and resigned his academic post in disgrace.
This week brings the news that a Johnson & Johnson subsidiary failed to include the deaths of two patients in a clinical trial of its new drug for heart failure, Natrecor, in an article published in the Journal of Emergency Medicine.
Why shouldn't we be surprised? Because over the last 25 years, clinical research has been largely privatized. Three-quarters of the clinical studies published in the three most respected medical journals (the New England Journal of Medicine, the Journal of the American Medical Assn. and the Lancet) are now commercially funded. As a result, our medical knowledge grows not in the direction that best improves our health but toward corporate profits, the way that plants grow toward sunlight. (...)"
Hier weiterlesen:
https://www.latimes.com/news/opinion/commentary/la-oe-abramson7jan07,0,1957242.story?coll=la-news-comment-opinions
Los Angeles Times, January 7, 2006
Aus: impf-report Newsletter Nr. 02/2006
rudkla - 22. Jan, 23:30
